BAYER AUTRALIA LIMITED — Clotrimazole Importer Profile
Pharmaceutical Importer · #3 buyer for Clotrimazole · $3.0M import value · 159 shipments · AUSTRALIA · DGFT Verified
BAYER AUTRALIA LIMITED is the #3 importer of Clotrimazole from India with $3.0M in import value and 159 verified shipments. BAYER AUTRALIA LIMITED holds a 3.2% market share in Clotrimazole imports based in AUSTRALIA. The company sources from 1 verified supplier across 60 formulations shipped to 1 country.
BAYER AUTRALIA LIMITED — Clotrimazole Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Clotrimazole to BAYER AUTRALIA LIMITED?
Verified from 159 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ENCUBE ETHICALS PRIVATE LIMITED | $3.0M | 159 | 100.0% |
BAYER AUTRALIA LIMITED sources Clotrimazole from 1 verified Indian supplier based on 159 customs records. The primary supplier is ENCUBE ETHICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does BAYER AUTRALIA LIMITED Compare to Nearest Clotrimazole Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | NUEVOS ETICOS NEOETHICALS S.A. | GUATEMALA | $3.8M | 76 | $50.0K |
| 3 | BAYER AUTRALIA LIMITED ★ | AUSTRALIA | $3.0M | 155 | $19.4K |
| 4 | GLENMARK PHARMACEUTICALS INC., USA | UNITED STATES | $2.1M | 179 | $12.0K |
| 5 | SALDENT INTERNACIONAL S.R.L., | DOMINICAN REPUBLIC | $1.7M | 41 | $41.5K |
BAYER AUTRALIA LIMITED ranks #3 among 1,728 Clotrimazole importers from India. Average shipment value of $19.4K compared to the market average of $11.3K. The closest competitors by value are NUEVOS ETICOS NEOETHICALS S.A. and GLENMARK PHARMACEUTICALS INC., USA.
Where Does BAYER AUTRALIA LIMITED Import Clotrimazole To?
Destination countries from 159 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $3.0M | 159 | 100.0% |
BAYER AUTRALIA LIMITED imports Clotrimazole to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $3.0M.
What Clotrimazole Formulations Does BAYER AUTRALIA LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| P CODE- 80618964 CLOTRIMAZOLE 2% VAGINA | $175.6K | 10 |
| P CODE- 80620136 CLOTRIMAZOLE 1% VAGINAL | $167.3K | 5 |
| P CODE- 80620136 CLOTRIMAZOLE 1% VAGINA | $161.0K | 8 |
| P CODE- 80620144 CLOTRIMAZOLE 1% CREAM | $137.2K | 10 |
| PRODUCT CODE - 80618964 CLOTRIMAZOLE 2%VAGINAL CREAM 20 GM. TUBE WITH 3 APPLICATOR PACK(CANESTEN 3 DAY CREAM 2% 20G AU) | $131.5K | 5 |
| PRODUCT CODE - 80620144 CLOTRIMAZOLE 1%CREAM 50 GM TUBE(CANESTEN CREAM 1% 50G-AUS) | $129.3K | 8 |
| P CODE- 80620152 CLOTRIMAZOLE 1% CREAM 2 | $110.0K | 6 |
| P CODE- 80620144 CLOTRIMAZOLE 1% CREAM 5 | $106.4K | 6 |
| P CODE- 80618964 CLOTRIMAZOLE 2% VAGINAL | $94.9K | 5 |
| PRODUCT CODE - 80618964 CLOTRIMAZOLE 2%VAGINAL CREAM 20 GM. TUBE WITH 3 APPLICATOR PACKCANESTEN 3 DAY CREAM 2% 20G AU | $94.3K | 4 |
BAYER AUTRALIA LIMITED imports 60 distinct Clotrimazole formulations from India. The top formulation is P CODE- 80618964 CLOTRIMAZOLE 2% VAGINA with 10 shipments worth $175.6K.
Regulatory Requirements: Importing Clotrimazole into Australia
What BAYER AUTRALIA LIMITED and other importers must comply with to import Clotrimazole from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Clotrimazole
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Clotrimazole from India and How Much Does BAYER AUTRALIA LIMITED Import?
India exported $19.5M worth of Clotrimazole through 10,037 shipments from 712 suppliers to 158 countries, serving 1,728 buyers globally. BAYER AUTRALIA LIMITED imports $3.0M of this total, accounting for 3.2% of India's Clotrimazole exports with 159 shipments from AUSTRALIA. This is verified from 159 customs shipment records covering 60 distinct formulations.
What Is the Average Order Value for BAYER AUTRALIA LIMITED's Clotrimazole Imports?
BAYER AUTRALIA LIMITED's average Clotrimazole order value is $19.1K per consignment, based on 159 shipments totaling $3.0M. BAYER AUTRALIA LIMITED is based in AUSTRALIA and ranks #3 among all Clotrimazole importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Clotrimazole to BAYER AUTRALIA LIMITED?
BAYER AUTRALIA LIMITED sources Clotrimazole from 1 verified Indian supplier: ENCUBE ETHICALS PRIVATE LIMITED ($3.0M, 100.0%). This is based on 159 customs records.
How Does BAYER AUTRALIA LIMITED Compare to Other Clotrimazole Importers?
BAYER AUTRALIA LIMITED ranks #3 among 1,728 Clotrimazole importers from India with a 3.2% market share. The top 3 importers are NUEVOS ETICOS NEOETHICALS S.A. ($3.8M), BAYER AUTRALIA LIMITED ($3.0M), GLENMARK PHARMACEUTICALS INC., USA ($2.1M). BAYER AUTRALIA LIMITED processed 159 shipments from AUSTRALIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clotrimazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clotrimazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BAYER AUTRALIA LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BAYER AUTRALIA LIMITED's capped import value divided by total capped export value for Clotrimazole across all Indian exporters.
- 5.Verified Records: This page is backed by 159 individual customs records matching BAYER AUTRALIA LIMITED importing Clotrimazole, covering 60 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 158+ countries, 1,728+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clotrimazole Import Data for BAYER AUTRALIA LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for BAYER AUTRALIA LIMITED's Clotrimazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BAYER AUTRALIA LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
BAYER AUTRALIA LIMITED × Clotrimazole
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BAYER AUTRALIA LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clotrimazole. For current order-level data, contact TransData Nexus.